TGTX
TG Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +20.0% ·
Aktienfluss -1.3% ·
neue Nettopositionen +16.7%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 117 | +11 | 84.53M | $4.64B | +13 | −2 |
| Q1 2026 | 109 | 0 | 78.24M | $2.60B | +7 | −7 |
| Q4 2025 | 108 | 0 | 85.68M | $2.55B | — | — |
| Q3 2025 | 18 | +1 | 56.55M | $2.04B | +1 | −1 |
| Q2 2025 | 15 | 0 | 56.34M | $2.03B | +1 | −1 |
| Q1 2025 | 12 | +2 | 14.38M | $567.04M | +2 | — |
| Q4 2024 | 10 | -1 | 14.56M | $438.37M | — | −1 |
| Q3 2024 | 10 | -3 | 5.57M | $130.22M | — | −3 |
| Q2 2024 | 13 | — | 11.93M | $212.32M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 7.43M | -19.2% | $293.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 3.28M | +2.8% | $129.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 3.28M | +2.8% | $129.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.21M | +1809.9% | $47.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 793.64K | +30.9% | $31.29M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 645.88K | +25.7% | $25.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 645.88K | +25.7% | $25.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 390.53K | +31.4% | $15.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 390.53K | +31.4% | $15.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Norges Bank ✦ (passiv) | 218.35K | -45.6% | $8.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 168.59K | Neu | $6.65M | 0.0% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 89.74K | Neu | $3.54M | 0.0% | New | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 61.93K | -63.2% | $2.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 61.93K | -63.2% | $2.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 46.73K | -8.3% | $1.84M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 35.29K | -48.0% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 35.29K | -48.0% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 35.29K | -48.0% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 35.29K | -48.0% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 35.29K | -48.0% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Renaissance Technologies | $6.65M | 0.0% |
| Millennium Management | $3.54M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 359 Inhaber, 105.22M Anteile, $3.44B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.